Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from North India

References

• Basu R, Brar JS, Chengappa KN, John V, Parepally H, Gershon S, et al. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype. Bipolar Disord 2004;6:314–318.
   PubMed Web of Science ®Google Scholar
• Chang HH, Chou CH, Chen PS, Gean PW, Huang HC, et al. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord 2009;117:124–129.
   PubMed Web of Science ®Google Scholar
• Correll CU, Frederickson AM, Kane JM, Manu P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord 2008;10:788–797.
   PubMed Web of Science ®Google Scholar
• D’Mello DA, Narang S, Agredano G. Prevalence and Consequences of Metabolic Syndrome in Bipolar Disorder. Psychiat Times 2007;24:1.
   Google Scholar
• Elmslie JL, Porter RJ, Joyce PR, Hunt PJ, Shand BI, Scott RS. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls. Aust N Z J Psychiatry 2009;43:53–60.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: Findings from the Bipolar Disorder Centre for Pennsylvanians. Bipolar Disord 2005;7:424–30.
   PubMed Web of Science ®Google Scholar
• Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 2008;20:131–137.
   PubMed Web of Science ®Google Scholar
• Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, et al. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008;106:197–201.
   PubMed Web of Science ®Google Scholar
• Grover S, Aggarwal M, Chakrabarti S, Dutt A, Avasthi A, Kulhara P, et al. Prevalence of metabolic syndrome in bipolar disorder: An exploratory study from North India. Prog Neuropsychopharmacol Biol Psychiatry 2012;36:141–146.
   PubMed Web of Science ®Google Scholar
• Guerreiro DF, Navarro R, Telles-Correia D, Martins P, Trigo E, Silva M. Effectivity of screening, concepts and attitudes towards metabolic syndrome: A study in bipolar patients followed in hospital Santa Maria psychiatric consultation. Acta Med Port 2010;23:173–182.
   PubMed Web of Science ®Google Scholar
• John AP, Koloth R, Dragovic M, Lim SC. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Australia 2009;190:176–179.
   PubMed Web of Science ®Google Scholar
• Kemp DE, Calabrese JR, Tran QV, Pikalov, A, Eudicone JM, Baker RA. Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: A post hoc analysis of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2010;71:1138–1144.
   PubMed Web of Science ®Google Scholar
• Maina G, D’Ambrosio V, Aguglia A, Paschetta E, Salvi V, Bogetto F. Bipolar disorders and metabolic syndrome: A clinical study in 185 patients. Riv Psichiatr 2010;45:34–40.
   PubMed Web of Science ®Google Scholar
• Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry 2008;30:318–323.
   PubMed Web of Science ®Google Scholar
• Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: A cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008;10:607–616.
   PubMed Web of Science ®Google Scholar
• Teixeira PJ, Rocha FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 2007;29:330–336.
   PubMed Web of Science ®Google Scholar
• Van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord 2008;10:342–348.
   PubMed Web of Science ®Google Scholar
• Van Winkel R, Van Os J, Celic I, Van Eyck D, Wampers M, Scheen A, et al. Psychiatric diagnosis as an independent risk factor for metabolic disturbances: Results from a comprehensive, naturalistic screening program. J Clin Psychiatry 2008;69:1319–1327.
   PubMed Web of Science ®Google Scholar
• Vuksan-Cusa B, Marcinko D, Nad S, Jakovljević M. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:109–112.
   PubMed Web of Science ®Google Scholar
• Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E, et al. Atypical antipsychotics related metabolic Syndrome in bipolar patients. J Affect Dis 2007;98:247–252.
   PubMed Web of Science ®Google Scholar
• Chang HH, Yang YK, Gean PW, Huang HC, Chen PS, Lu RB. The role of valproate in metabolic disturbances in bipolar disorder patients. J Affect Dis 2010;124:319–323.
   PubMed Web of Science ®Google Scholar
• Bowden DW, Rudoc M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, et al. Coincident linkage of Type 2 diabetes, metabolic syndrome and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 2006;55:1985–1994.
   PubMedGoogle Scholar
• De Hert MA, vanWinkel R, van Eyck D, Hanssens L, Wampers M, Scheen A, et al. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res 2006;83:87–93.
   PubMed Web of Science ®Google Scholar
• De Hert M, Schreurs V, Sweers K, Van Eyck D, Hanssens L, Sinko S, et al. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review. Schizophr Res 2008;101:295–303.
   PubMed Web of Science ®Google Scholar
• Correll CU, Frederickson AM, Kane JM, Manu P. Does antipsychotic polypharmacy increase the risk for metabolic syndrome?. Schizophr Res 2007;89:91–100.
   PubMed Web of Science ®Google Scholar
• Hasnain M, Fredrickson SK, Vieweg WV, Pandurangi AK. Metabolic syndrome associated with schizophrenia and atypical antipsychotics. Cur Diabetes Rep 2010;10:209–216.
   PubMed Web of Science ®Google Scholar
• McEvoy JP, Mayer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005;80:19–32.
   PubMed Web of Science ®Google Scholar
• Allison DB, Newcomer JN, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, et al. Obesity among those with mental disorders: A National Institute of Mental Health Meeting Report. Am Prev Med 2009;36:341–350.
   PubMed Web of Science ®Google Scholar
• Limosin F, Gasquet I, Leguay D. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia. Acta Psychiat Scand 2008;118:19–25.
   PubMed Web of Science ®Google Scholar
• World Health Organization: The ICD-10 classification of mental and behavioural disorders—Clinical descriptions. and diagnostic guidelines. Geneva: WHO; 1992.
   Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—A new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med 2005;23:469–480.
   Google Scholar
• Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.
   Google Scholar
• Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 2004;27: 1182–1186.
   PubMed Web of Science ®Google Scholar
• Misra A, Wasir JS, Pandey RM. An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians. Diabetes Care 2005;28:398–403.
   PubMed Web of Science ®Google Scholar
• Sahoo S, Ameen S, Akhtar S. Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: A six week prospective study in Indian female patients. Schizophr Res 2007;95:247.
   PubMed Web of Science ®Google Scholar
• Sahoo S, Narayana M, Shahul A, Sayeed A. Metabolic syndrome in first episode schizophrenia: A randomized double-blind controlled short-term prospective study. Schizophr Res 2008;101: 266–272.
   PubMed Web of Science ®Google Scholar
• Padmawati R, McCreadle RG, Tirupati S. Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia. Schizophr Res 2010;121:199–202.
   PubMed Web of Science ®Google Scholar
• Grover S, Nebhinani N, Chakrabarti S, Parakh P, Ghormode D. Metabolic syndrome in antipsychotic naïve patient diagnosed with schizophrenia. Early Interv Psychiatry 2012;6:326–331.
   PubMed Web of Science ®Google Scholar
• Grover S, Nebhinani N, Chakrabarti S, Avasthi A, Kulhara P. Prevalence of metabolic syndrome in subjects receiving clozapine: A study from India. Indian J Pharmacology 2011;43:591–595.
   PubMed Web of Science ®Google Scholar
• Bond DJ, Kunz M, Torres IJ, Lam RW, Yatham LN. The association of weight gain with mood symptoms and functional outcomes following a first manic episode: Prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Bipolar Disord 2010;12:616–626.
   PubMed Web of Science ®Google Scholar
• De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 2011;8:114–126.
   PubMed Web of Science ®Google Scholar